{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:06:54Z","timestamp":1793203614476,"version":"4.5.0"},"reference-count":47,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T00:00:00Z","timestamp":1716336000000},"content-version":"unspecified","delay-in-days":21,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Arthropharm PTY LTD","award":["NA"],"award-info":[{"award-number":["NA"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,5,3]]},"published-print":{"date-parts":[[2024,5]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Knee osteoarthritis (OA) is the most prevalent arthritis type and a leading cause of chronic mobility disability. While pain medications provide only symptomatic pain relief; growing evidence suggests pentosan polysulfate sodium (PPS) is chondroprotective and could have anti-inflammatory effects in knee OA. This study aims to explore the efficacy and safety of oral PPS in symptomatic knee OA with dyslipidaemia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>MaRVeL is a phase II, single-centre, parallel, superiority trial which will be conducted at Royal North Shore Hospital, Sydney, Australia. 92 participants (46 per arm) aged 40 and over with painful knee OA and mild to moderate structural change on X-ray (Kellgren and Lawrence grade 2 or 3) will be recruited from the community and randomly allocated to receive two cycles of either oral PPS or placebo for 5 weeks starting at baseline and week 11. Primary outcome will be the 16-week change in overall average knee pain severity measured using an 11-point Numeric Rating Scale. Main secondary outcomes include change in knee pain, patient global assessment, physical function, quality of life and other structural changes. A biostatistician blinded to allocation groups will perform the statistical analysis according to the intention-to-treat principle.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>The protocol has been approved by the NSLHD Human Research Ethics Committee (HREC) (2021\/ETH00315). All participants will provide written informed consent online. Study results will be disseminated through conferences, social media and academic publications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration numbers<\/jats:title>\n                    <jats:p>Australian New Zealand Clinical Trial Registry (ACTRN12621000654853); U1111-1265-3750.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-083046","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T13:30:24Z","timestamp":1716384624000},"page":"e083046","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of pentosan polysulfate sodium in people with symptomatic knee osteoarthritis and dyslipidaemia: protocol of the MaRVeL trial"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9964-599X","authenticated-orcid":false,"given":"Md Abu Bakar","family":"Siddiq","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"},{"name":"Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"},{"name":"Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatyana","family":"Fedorova","sequence":"additional","affiliation":[{"name":"The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bracken","sequence":"additional","affiliation":[{"name":"Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"},{"name":"Musculoskeletal Health, Arabanoo Precinct, Kolling Institute, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonika","family":"Virk","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"},{"name":"Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venkatesha","family":"Venkatesha","sequence":"additional","affiliation":[{"name":"Rheumatology Department, Royal North Shore Hospital, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdolhay","family":"Farivar","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"},{"name":"Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Win Min","family":"Oo","sequence":"additional","affiliation":[{"name":"Rheumatology, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"},{"name":"University of Medicine, Mandalay, Mandalay, Myanmar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Linklater","sequence":"additional","affiliation":[{"name":"Castlereagh Imaging, St Leonard, NSW, St Leonard, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Cullis","family":"Hill","sequence":"additional","affiliation":[{"name":"Arthropharm Pty Ltd, St Leonard, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3197-752X","authenticated-orcid":false,"given":"David J","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Royal North Shore Hospital, Northern Clinical School, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia"},{"name":"Sydney Musculoskeletal Health, The University of Sydney, Sydney, New South Wales, Australia, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2024,5,22]]},"reference":[{"key":"2025121300085311000_14.5.e083046.1","doi-asserted-by":"publisher","DOI":"10.2105\/AJPH.84.3.351"},{"key":"2025121300085311000_14.5.e083046.2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.5694\/j.1326-5377.2008.tb01918.x","article-title":"Estimating prevalence of common chronic morbidities in Australia","volume":"189","author":"Knox","year":"2008","journal-title":"Med J Aust"},{"key":"2025121300085311000_14.5.e083046.3","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00003086-198612000-00011","article-title":"Nonsteroidal anti-inflammatory drugs in treatment of osteoarthritis","volume":"213","author":"Brandt","year":"1986","journal-title":"Clin Orthop Relat Res"},{"key":"2025121300085311000_14.5.e083046.4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/art.1790100109","article-title":"Costs and effectiveness of nonsteroidal anti-inflammatory drugs: the importance of reducing side effects","volume":"10","author":"Gabriel","year":"1997","journal-title":"Arthritis Rheumatol"},{"key":"2025121300085311000_14.5.e083046.5","doi-asserted-by":"crossref","unstructured":"Carr AJ , Helkin A , Stein JJ , et al . Dyslipidemia part 1. review of lipid metabolism and vascular cell physiology. Vasc Endovasc Surg 2016. doi:10.1177\/1538574416628654","DOI":"10.1177\/1538574416628654"},{"key":"2025121300085311000_14.5.e083046.6","doi-asserted-by":"publisher","DOI":"10.1177\/1538574416628654"},{"key":"2025121300085311000_14.5.e083046.7","first-page":"1118","article-title":"Association between metabolic factors and knee osteoarthritis in women: the Chingford study","volume":"22","author":"Hart","year":"1995","journal-title":"J Rheumatol"},{"key":"2025121300085311000_14.5.e083046.8","first-page":"1827","article-title":"Serum cholesterol and osteoarthritis. The baseline examination of the Ulm osteoarthritis study","volume":"25","author":"St\u00fcrmer","year":"1998","journal-title":"J Rheumatol"},{"key":"2025121300085311000_14.5.e083046.9","first-page":"745","article-title":"Radiographic osteoarthritis and serum cholesterol","volume":"24","author":"Al-Arfaj","year":"2003","journal-title":"Saudi Med J"},{"key":"2025121300085311000_14.5.e083046.10","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-016-2782-x","article-title":"Prevalence and associated factors of knee osteoarthritis in a rural Chinese adult population: an Epidemiological survey","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Public Health"},{"key":"2025121300085311000_14.5.e083046.11","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1080\/00365513.2017.1354255","article-title":"Metabolic factors and oxidative stress in osteoarthritis: a case-control study","volume":"77","author":"Tootsi","year":"2017","journal-title":"Scand J Clin Lab Invest"},{"key":"2025121300085311000_14.5.e083046.12","doi-asserted-by":"publisher","DOI":"10.2174\/1573397111666150522093337"},{"key":"2025121300085311000_14.5.e083046.13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1043"},{"key":"2025121300085311000_14.5.e083046.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2012.11.003"},{"key":"2025121300085311000_14.5.e083046.15","doi-asserted-by":"publisher","DOI":"10.1002\/art.33443"},{"key":"2025121300085311000_14.5.e083046.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-203248"},{"key":"2025121300085311000_14.5.e083046.17","doi-asserted-by":"crossref","DOI":"10.1186\/ar4367","article-title":"Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis","volume":"15","author":"de Munter","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"2025121300085311000_14.5.e083046.18","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.joca.2015.11.016","article-title":"High LDL levels lead to increased Synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis","volume":"24","author":"de Munter","year":"2016","journal-title":"Osteoarthritis and Cartilage"},{"key":"2025121300085311000_14.5.e083046.19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/art.39337","article-title":"Regulation of cholesterol homeostasis by hedgehog signaling in Osteoarthritic cartilage","volume":"68","author":"Ali","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025121300085311000_14.5.e083046.20","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2012.135"},{"key":"2025121300085311000_14.5.e083046.21","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0038-1661640","article-title":"Anticoagulant activities of Pentosan Polysulphate (H\u00e9moclar) due to release of hepatic Triglyceride Lipase (HTGL)","volume":"56","author":"Barrowcliffe","year":"1986","journal-title":"Thromb Haemost"},{"key":"2025121300085311000_14.5.e083046.22","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-201X.1997.504239000.x"},{"key":"2025121300085311000_14.5.e083046.23","doi-asserted-by":"publisher","DOI":"10.1006\/phrs.1993.1029"},{"key":"2025121300085311000_14.5.e083046.24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1748-5827.1996.tb02355.x","article-title":"Systemic use of Pentosan Polysulphate in the treatment of osteoarthritis","volume":"37","author":"Read","year":"1996","journal-title":"J Small Anim Pract"},{"key":"2025121300085311000_14.5.e083046.25","doi-asserted-by":"publisher","DOI":"10.1136\/vr.146.15.433"},{"key":"2025121300085311000_14.5.e083046.26","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20170355"},{"key":"2025121300085311000_14.5.e083046.27","doi-asserted-by":"crossref","unstructured":"Greenlee T , Hom G , Conti T , et al . Re: Pearce et al.: Pigmentary Maculopathy associated with chronic exposure to Pentosan Polysulfate sodium (Ophthalmology. Ophthalmology 2019;126. doi:10.1016\/j.ophtha.2018.12.037","DOI":"10.1016\/j.ophtha.2018.12.037"},{"key":"2025121300085311000_14.5.e083046.28","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(80)90018-3"},{"key":"2025121300085311000_14.5.e083046.29","unstructured":"Klocking HP . Influence of Pentosan Polysulfate sodium compared with other Polyanionic compounds on the t-PA and PAI-1 activity. Perfusion 1994;32\u20138."},{"key":"2025121300085311000_14.5.e083046.30","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.rvsc.2018.11.028","article-title":"Anti-Arthritic effect of Pentosan Polysulfate in rats with collagen-induced arthritis","volume":"122","author":"Suranji Wijekoon","year":"2019","journal-title":"Res Vet Sci"},{"key":"2025121300085311000_14.5.e083046.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222602","article-title":"Human Osteocyte expression of nerve growth factor: the effect of Pentosan Polysulphate sodium (PPS) and implications for pain associated with knee osteoarthritis","volume":"14","author":"Stapledon","year":"2019","journal-title":"PLoS ONE"},{"key":"2025121300085311000_14.5.e083046.32","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0011-393X(00)88499-4","article-title":"Effects of calcium Pentosan Polysulfate on joint inflammation and pouch fluid levels of leukocytes, nitric oxide, and Interleukin-6 in a rat model of arthritis","volume":"60","author":"Smith","year":"1999","journal-title":"Current Therapeutic Research"},{"key":"2025121300085311000_14.5.e083046.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370118"},{"key":"2025121300085311000_14.5.e083046.34","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00224-15"},{"key":"2025121300085311000_14.5.e083046.35","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(99)80021-3"},{"key":"2025121300085311000_14.5.e083046.36","doi-asserted-by":"crossref","unstructured":"Liu X , Virk S , Fedorova T , et al . The effect of Pentosan Polysulfate sodium for improving Dyslipidaemia and knee pain in people with knee osteoarthritis: A pilot study. Osteoarthr Cartil Open 2023;5. doi:10.1016\/j.ocarto.2023.100343","DOI":"10.1016\/j.ocarto.2023.100343"},{"key":"2025121300085311000_14.5.e083046.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780290816"},{"key":"2025121300085311000_14.5.e083046.38","doi-asserted-by":"publisher","DOI":"10.2519\/jospt.1998.28.2.88"},{"key":"2025121300085311000_14.5.e083046.39","doi-asserted-by":"publisher","DOI":"10.1007\/s40271-013-0036-x"},{"key":"2025121300085311000_14.5.e083046.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2011.05.004"},{"key":"2025121300085311000_14.5.e083046.41","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181095"},{"key":"2025121300085311000_14.5.e083046.42","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X132488"},{"key":"2025121300085311000_14.5.e083046.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2011.03.007"},{"key":"2025121300085311000_14.5.e083046.44","unstructured":"Pereira A , Demolle D , Gossuin C , et al . Multidimensional personality questionnaire (Mpsq) Tools4Patient. method for prediction of a placebo response in an individual. Patent US 2017.:US2017."},{"key":"2025121300085311000_14.5.e083046.45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2016.01.074","article-title":"Characterization and prediction of placebo responders in peripheral neuropathic patients in a 4-week analgesic clinical trial","volume":"17","author":"Pereira","year":"2016","journal-title":"The Journal of Pain"},{"key":"2025121300085311000_14.5.e083046.46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-061627","article-title":"Effect of motion control versus neutral walking footwear on pain associated with lateral Tibiofemoral joint osteoarthritis: a comparative effectiveness randomised clinical trial","volume":"12","author":"Paterson","year":"2022","journal-title":"BMJ Open"},{"key":"2025121300085311000_14.5.e083046.47","doi-asserted-by":"crossref","first-page":"276","DOI":"10.11613\/BM.2012.031","article-title":"Interrater reliability: the Kappa Statistic","volume":"22","author":"McHugh","year":"2012","journal-title":"Biochem Med (Zagreb)"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-083046","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:09:05Z","timestamp":1765613345000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-083046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":47,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5,22]]},"published-print":{"date-parts":[[2024,5]]}},"alternative-id":["10.1136\/bmjopen-2023-083046"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-083046","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5]]}}}